Kec (092220) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
15 Jul, 2026Executive summary
Specializes in non-memory power semiconductors, supplying major domestic and global electronics and automotive firms, with a growing export focus on China, Japan, and the US.
Operates 11 overseas subsidiaries and sales networks, with consolidated sales of KRW 123.4 billion for H1 2025.
Maintains strong R&D capabilities, holding 122 intellectual property rights and investing 2.4% of sales in R&D.
Financial highlights
H1 2025 consolidated revenue: KRW 123.4 billion, down from KRW 243.2 billion in H1 2024.
Operating loss: KRW -8.2 billion (H1 2024: -13.3 billion); net loss: KRW -6.0 billion (H1 2024: -11.0 billion).
Cash and cash equivalents at period end: KRW 12.2 billion (down from KRW 30.6 billion at 2024 year-end).
Total assets: KRW 449.4 billion; total equity: KRW 339.4 billion.
Outlook and guidance
Global semiconductor market expected to grow 12.7% in 2025, with SSTR segment rebounding by 1.7% after a decline in 2024.
Company aims to expand in automotive semiconductors and maintain R&D investment for product innovation.
Latest events from Kec
- Revenue fell and losses narrowed in H1 2026, with strategic restructuring actions taken.092220
Q2 2026 - Returned to net profit in H1 2024 with improved margins and full control of Thai subsidiary.092220
Q2 2024 - Revenue up 17.5% but net loss persists; global expansion and R&D investments ongoing.092220
Q4 2024 - Q1 2025 revenue reached KRW 63.6B with a net loss of KRW 2.28B amid ongoing R&D and global focus.092220
Q1 2025 - Net loss widened to KRW 26.6 billion on 5.6% lower sales, with ongoing investments in production capacity.092220
Q4 2025 - Revenue fell and losses narrowed, with full Thai subsidiary ownership and strong global focus.092220
Q3 2024 - Q1 2026 saw a net loss, negative cash flow, and a reverse stock split to stabilize shares.092220
Q1 2026 - 2025 YTD sales fell to KRW 175.9B with a net loss of KRW 13.4B; major capital and R&D investments ongoing.092220
Q3 2025